Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform

After co-founding two biotechs off virus-based therapies, one for pain and one for cancer, Ken Greenberg decided to go in a different direction for his newest biotech, SonoThera. Based out of San Francisco, SonoThera announced Monday morning that it raised $60.75 million to develop new gene therapies — but delivered…

...

Click to view original post